These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3611312)

  • 41. Reliability of cefaclor, cefazolin, cefamandole, and cephalothin disks to predict susceptibility of Enterobacteriaceae, Staphylococcus species, and Haemophilus influenzae.
    Barry AL; Jones RN; Thornsberry C
    Am J Clin Pathol; 1985 Nov; 84(5):643-8. PubMed ID: 3877452
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In-vitro activity of five beta-lactam/beta-lactamase inhibitor combinations against consecutive isolates of the Enterobacteriaceae and Pseudomonas aeruginosa.
    McLaughlin JC; Barry AL; Fuchs PC; Gerlach EH; Hardy DJ; Pfaller MA
    J Antimicrob Chemother; 1994 Feb; 33(2):223-30. PubMed ID: 8182003
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The in vitro activity of the newer beta-lactam antibiotics against 124 strains of gram-negative bacilli.
    Dixson S; Andrew JH
    Pathology; 1985 Oct; 17(4):636-9. PubMed ID: 3938006
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of Oxacillin and Cefoxitin Disk Diffusion and Microbroth Dilution Methods for Detecting
    Naccache SN; Callan K; Burnham CA; Wallace MA; Westblade LF; Dien Bard J;
    J Clin Microbiol; 2019 Dec; 57(12):. PubMed ID: 31462553
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Appraisal of disk sensitivity tests with mecillinam.
    Anderson JD; Aird MY; Eftekhar F; Morrison BJ
    Chemotherapy; 1981; 27(2):106-13. PubMed ID: 6258872
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incidence of inducible beta-lactamases in gram-negative septicemia isolates from twenty-nine European laboratories. European Study Group on Antibiotic Resistance.
    Eur J Clin Microbiol; 1987 Aug; 6(4):460-6. PubMed ID: 3117535
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of a predictor panel to evaluate susceptibility testing methods for ampicillin-sulbactam.
    Bradford PA; Sanders CC
    Antimicrob Agents Chemother; 1993 Feb; 37(2):251-9. PubMed ID: 8452355
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies to optimize the in vitro testing of piperacillin combined with tazobactam (YTR 830).
    Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1989; 12(6):495-510. PubMed ID: 2560422
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discordant results between the broth disk elution and broth microdilution susceptibility tests with Bacteroides fragilis group isolates.
    Aldridge KE; Henderberg A; Schiro DD; Sanders CV
    J Clin Microbiol; 1990 Feb; 28(2):375-8. PubMed ID: 2312684
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
    Zhang H; Yang Q; Liao K; Ni Y; Yu Y; Hu B; Sun Z; Huang W; Wang Y; Wu A; Feng X; Luo Y; Hu Z; Chu Y; Chen S; Cao B; Su J; Gui B; Duan Q; Zhang S; Shao H; Kong H; Badal RE; Xu Y
    Antimicrob Agents Chemother; 2016 Jan; 60(1):245-51. PubMed ID: 26482308
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antimicrobial activity of beta-lactams against multiresistant micro-organisms from the family Enterobacteriaceae, and genus Pseudomonas.
    Niebla A; González I; Vallín C
    Microbios; 1994; 80(325):245-50. PubMed ID: 7700163
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro susceptibility of bovine mastitis pathogens to a combination of penicillin and framycetin: development of interpretive criteria for testing by broth microdilution and disk diffusion.
    Pillar CM; Stoneburner A; Shinabarger DL; Abbeloos E; Goby L; Bradley AJ
    J Dairy Sci; 2014 Oct; 97(10):6594-607. PubMed ID: 25129497
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
    Hall WH; Opfer BJ; Gerding DN
    Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methodological implications of testing anaerobe susceptibility to cephalosporins (cefazolin, cefamandole, cefoxitin).
    Krasemann C; Werner H; Hildenbrand G; Benning M; Brandt U; Ungerechts J
    Infection; 1980; 8 Suppl 2():S182-6. PubMed ID: 6969693
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [In vitro comparative study of piperacillin-aminoglycosides combinations against Enterococci and Enterobacteriaceae].
    Chanal M; Sirot D; Cluzel M; Sirot J; Rubio D; Joly B; Cluzel R
    Presse Med; 1986 Dec; 15(46):2313-6. PubMed ID: 2949274
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibitory and bactericidal activity of selected beta-lactam agents alone and in combination with beta-lactamase inhibitors compared with that of cefoxitin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group.
    Stratton CW; Weeks LS; Aldridge KE
    Diagn Microbiol Infect Dis; 1992; 15(4):321-30. PubMed ID: 1611847
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activity of cefamandole, cefoxitin, ampicillin and gentamicin against 419 bacteria isolated from blood of patients with sepsis.
    Mirrett S; Reller LB
    Chemotherapy; 1980; 26(6):436-45. PubMed ID: 7408556
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of in vitro antimicrobial activity of cefamandole and cefazolin with cephalothin against over 8,000 clinical bacterial isolates.
    Jones RN; Fuchs PC
    Antimicrob Agents Chemother; 1976 Jun; 9(6):1066-9. PubMed ID: 938021
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative in vitro activity of azlocillin, ampicillin, mezlocillin, piperacillin, and ticarcillin, alone and in combination with an aminoglycoside.
    White GW; Malow JB; Zimelis VM; Pahlavanzadeh H; Panwalker AP; Jackson GG
    Antimicrob Agents Chemother; 1979 Apr; 15(4):540-3. PubMed ID: 111616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amdinocillin in combination with beta-lactam antibiotics for treatment of serious gram-negative infections.
    Rotstein C; Farrar WE
    Am J Med; 1983 Aug; 75(2A):96-9. PubMed ID: 6311014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.